Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib: a case report

Authors

  • Sara Valpione University of Padova; Melanoma and Esophageal Cancer Unit IOV-IRCCS

Abstract

We here describe the clinical course of a V600E BRAF mutated metastatic melanoma patient with systemic disease, who developed tumor progression on superficial soft-tissue metastases during treatment with dabrafenib. Bleomycin electrochemotherapy during dabrafenib treatment was administered to control the soft-tissue progressing metastases and ensured sustained local control without significant toxicity. This combined approach maintained the patient quality of life and allowed for the prosecution of the target therapy, which proved to be still effective on systemic disease, up to 17 months.

 

Downloads

Published

2015-02-11

How to Cite

Valpione, S. (2015). Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib: a case report. Radiology and Oncology, 49(1). Retrieved from https://www.radioloncol.com/index.php/ro/article/view/2185

Issue

Section

Clinical oncology